143
Participants
Start Date
November 30, 2007
Primary Completion Date
October 31, 2012
Study Completion Date
January 31, 2013
pioglitazone
daily dose, 30 mg daily for 2 weeks followed by 45 mg daily until completing 3 months unless higher dose not tolerated in which case patient remained at 30 mg daily
Sublingual nitroglycerine
Used during nitroglycerin-mediated dilatation vascular function measures in both arms of the study if patient's blood pressure permitted. One single tablet was used per vascular test performed.
University of Michigan, Ann Arbor
National Heart, Lung, and Blood Institute (NHLBI)
NIH
University of Michigan
OTHER